<DOC>
	<DOCNO>NCT00636116</DOCNO>
	<brief_summary>The purpose study establish F ( ab ) 2 antivenom ( Anavip ) safe crotalinae envenomation . Confirm effectiveness prevent occurrence delay coagulopathies compare safety efficacy Fab antivenom ( CroFab ) patient Crotalinae envenomation .</brief_summary>
	<brief_title>Phase 3 Multicenter Comparative Study Confirm Safety Effectiveness F ( ab ) 2 Antivenom Anavip .</brief_title>
	<detailed_description>Fewer 200,000 crotaline envenomations occur annually US.Crotaline venom contain broad variety toxin , venom variability injection quantity among individual snake across specie result broadly variable patient presentation . Clinical consequence crotaline envenomation include local systemic effect , may progress hour days.The best studied systemic consequence coagulopathy , may complexity mimic disseminated intravascular coagulation . Platelet clot disorder respond rapidly administration polyvalent antivenom . Crotaline viper envenomation United States treat one two licensed product : Wyeth Antivenin ( Crotalidae ) Polyvalent ( Polyvalent ) , CroFab® ( antivenin Crotalidae polyvalent immune Fab , ovine ) . In recent year , product critically short supply . Use Wyeth Polyvalent associate great 75 % incidence adverse reaction , include acute type 1 delay type 2 immune reactions.These phenomenon inherent risk use whole immunoglobulin . CroFab´s low molecular weight create pharmacokinetic mismatch crotaline venom leds recurrent venom effect . Anavip pharmacologically pharmacokinetically different.Because elimination Fc portion immunoglobulin molecule , Anavip expect produce far few adverse reaction see whole immunoglobulin antivenoms unlike Fab molecule , F ( ab ) 2 molecule exceed size threshold renal clearance thus expect remain circulation significantly long time substantially reduce incidence recurrent coagulopathy .</detailed_description>
	<mesh_term>Snake Bites</mesh_term>
	<mesh_term>Antivenins</mesh_term>
	<criteria>Men woman 2 80 year age Presenting emergency treatment pit viper bite Informed consent document read sign patient ( parent/legal guardian ) Current use antivenom , use within last month Current participation clinical drug study , participation within last month Positive urine blood pregnancy test screen Breastfeeding Allergy horse serum , sheep serum , papaya Underlying medical condition significantly alter platelet count fibrinogen ; thrombocytopenia , hemophilia , familial dysfibrinogenemia , leukemia Use medication expect affect platelet count , coagulation factor fibrinogen : chemotherapeutic agent , warfarin , heparin No clinical indication snake bite require antivenom treatment</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>snake bite</keyword>
	<keyword>antivenin treatment</keyword>
</DOC>